Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This pilot, multi center study will establish the effectiveness of Given PillCam® Platform with the PillCam® Colon 2 Capsule as demonstrated by the identification of subjects with polyps, compared to standard colonoscopy.

This study will also use to evaluate the administrative feasibility and data management of study design.

NCT number	NCT01269372
Study type	Interventional
Source	Medtronic - MITG
Contact
Status	Completed
Phase	N/A
Start date	December 2010
Completion date	July 2011

Status	Clinical Trial	Phase
Recruiting	`NCT05347446` - Hybrid Versus Non-Hybrid Endoscopic Submucosal Dissection for Colorectal Polyps (SHORT-ESD)	N/A
Recruiting	`NCT06399120` - Diagnostic Performance of Endocytoscopy for Colorectal Lesions
Not yet recruiting	`NCT06133387` - PARADIGM - En Bloc Trial With the EndoQuest ELS System	N/A

Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms